These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2441754)

  • 1. Methyltrypsin: a novel probe of proteinase-inhibitor interactions.
    Magnotti RA
    Biochim Biophys Acta; 1987 Sep; 915(1):46-52. PubMed ID: 2441754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of alpha 2-antiplasmin as a model for the demonstration of complex reversibility in serpins.
    Shieh BH; Potempa J; Travis J
    J Biol Chem; 1989 Aug; 264(23):13420-3. PubMed ID: 2474530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between the binding of trypsin and chymotrypsin by alpha 1-proteinase inhibitor.
    Hercz A
    Biochem Biophys Res Commun; 1986 Jul; 138(2):925-30. PubMed ID: 3488739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique pathway for the plasma elimination of alpha 2-antiplasmin-protease complexes in mice.
    Gonias SL; Fuchs HE; Pizzo SV
    Thromb Haemost; 1982 Oct; 48(2):208-10. PubMed ID: 6758181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cationic and anionic trypsins: differences of interaction with alpha 1-proteinase inhibitor.
    Vercaigne-Marko D; Carrère J; Guy-Crotte O; Figarella C; Hayem A
    Biol Chem Hoppe Seyler; 1989 Nov; 370(11):1163-71. PubMed ID: 2610933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of human alpha1-antitrypsin with anhydrotrypsin.
    Moroi M; Yamasaki M; Aoki N
    J Biochem; 1975 Nov; 78(5):925-8. PubMed ID: 1082451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and immunoreactive alpha 1 proteinase inhibitor in bronchoalveolar lavages: methodological studies.
    el Yamani J; Hayem A; Lafitte JJ; Gressier B; Mizon J
    Bull Eur Physiopathol Respir; 1986; 22(4):359-63. PubMed ID: 3094607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-2-plasmin inhibitor comprises a single domain.
    Magnotti RA; Halsall HB
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1062-70. PubMed ID: 2945559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
    Hall P; Tryon E; Nikolai TF; Roberts RC
    Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of alpha 1-proteinase inhibitor and alpha 2-macroglobulin in serum and lung secretions of intubated infants.
    Bruce MC; Martin RJ; Boat TF
    Pediatr Res; 1984 Jan; 18(1):35-40. PubMed ID: 6199725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anhydrotrypsin and trypsin: subtle difference in the active-site conformations detected by chemical modification and CD spectroscopy.
    Yokosawa H; Ishii S
    J Biochem; 1977 Mar; 81(3):657-63. PubMed ID: 405379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
    Kress LF
    J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the interaction of alpha2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteases.
    Moroi M; Aoki N
    Biochim Biophys Acta; 1977 Jun; 482(2):412-20. PubMed ID: 141946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of pi, tau-dimethylhistidine on alkylation of trypsin with active-site-directed sulfonic acid methyl esters.
    Schubert C; Fiedler F
    J Enzyme Inhib; 1994; 8(3):173-85. PubMed ID: 7539486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence labeling of a single sulfhydryl group in human plasma alpha 1-proteinase inhibitor and characterization of the labeled inhibitor.
    Shimokawa Y; Abe O; Kuromizu K
    J Biochem; 1986 Sep; 100(3):563-70. PubMed ID: 3491067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical assay of proteinase inhibitors using polycation-sensitive membrane electrode detection.
    Badr IH; Ramamurthy N; Yang VC; Meyerhoff ME
    Anal Biochem; 1997 Jul; 250(1):74-81. PubMed ID: 9234901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory mediators and modulators released in organ culture from rabbit skin lesions produced in vivo by sulfur mustard. III. Electrophoretic protein fractions, trypsin-inhibitory capacity, alpha 1-proteinase inhibitor, and alpha 1- and alpha 2-macroglobulin proteinase inhibitors of culture fluids and serum.
    Harada S; Dannenberg AM; Vogt RF; Myrick JE; Tanaka F; Redding LC; Merkhofer RM; Pula PJ; Scott AL
    Am J Pathol; 1987 Jan; 126(1):148-63. PubMed ID: 2433944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine pancreatic trypsin inhibitor-trypsin complex as a detection system for recombinant proteins.
    Borjigin J; Nathans J
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):337-41. PubMed ID: 7678346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.